‘Green’ Catalysis Technique Aims to Boost Pharmaceutical Manufacturing Efficiency

Diagram of the microsphere-packed, tubular reactor used in the new "pseudo-homogeneous" catalysis technique.

About 70 percent of pharmaceuticals are manufactured using palladium-driven catalytic processes that are either fast or efficient – but not both. Researchers at North Carolina State University have now developed a green chemistry method that combines aspects of both processes to improve efficiency at a minimal cost of processing time.

Tubular reactor containing microspheres (top); close-up of the microspheres (bottom). Image credit: Milad Abolhasani. Click to enlarge.

Specifically, these palladium-driven catalytic reactions are used to connect carbons in small, organic molecules to create larger molecules for use in pharmaceuticals and other applications. Traditionally, there have been two ways to do this.

In homogeneous processes, palladium is dissolved in solution, allowing maximum exposure to the organic molecules, or reagents. This makes the process very fast, but results in a lot of palladium either being wasted (because it gets thrown out after target molecules are harvested) or being recovered at high cost (because the recovery process is expensive).

In heterogeneous processes, palladium is fixed to a hard substrate in a pack-bed reactor, and the reagents are run through the reactor. This takes much longer, but little or no palladium is wasted.

“We’ve created and tested a new process called pseudo-homogeneous catalysis, which combines the best of both worlds: it is nearly as fast as homogeneous catalysis, while it preserves virtually all of the palladium,” says Milad Abolhasani, an assistant professor of chemical engineering at NC State and corresponding author of a paper on the work.

The new technique relies on novel, elastic silicone-chemistry based microspheres developed by the research team using microfluidics.

“We used a microfluidic strategy to make elastomeric microspheres with a narrow size distribution to make them ‘loadable’ into a tubular reactor without clogging,” Abolhasani says. “That was essential, because conventional batch scale polymerization techniques result in elastomeric microspheres with a large size distribution that would clog the reactor when loaded.” Video of the process for creating the microspheres is available at https://youtu.be/YwkFvMhtIdk.

Each silicone microsphere is loaded with palladium. Reagents then pass through the microsphere and interact with the palladium. The resulting pharmaceutical target molecules leave the microsphere again – but the palladium remains trapped in the microsphere.

“The flexible spheres allow the palladium catalyst to ‘settle’ inside the microreactor environment,” says Jan Genzer, the S. Frank and Doris Culberson Distinguished Professor of Chemical and Biomolecular Engineering at NC State, and a co-author of the paper. “The flexibility of the silicone sphere allows the palladium catalyst to adopt very many configurations during the reaction – as is the case in homogeneous processes. The palladium catalyst is retained for further use – as is the case in heterogeneous processes.”

“In proof-of-concept testing, our process was much faster than any heterogeneous techniques, but still marginally slower than conventional homogeneous processes,” Abolhasani says. “We’re currently working on optimizing the properties of our elastic microspheres to improve the reaction yield.”

One other advantage of the pseudo-homogeneous technique is that it makes use of nontoxic solvents, i.e., water and ethanol. Conventional homogeneous techniques use typically organic solvents, such as toluene, which are not environmentally benign.

“It is important to demonstrate that green chemistry approaches can be used to make a process that is, in all, more efficient than existing techniques,” Abolhasani says. “You do not have to trade safety for cost-effectiveness.”

The paper, “Microfluidic Synthesis of Elastomeric Microparticles: A Case Study in Catalysis of Palladium-Mediated Cross-Coupling,” is published in the AIChE Journal. The paper was co-authored by Jeffrey Bennet, a Ph.D. student in Abolhasani’s lab; Andrew Kristof, an undergraduate at NC State; Vishal Vasudevan, a visiting undergraduate at NC State; and Jiri Srogl, an adjunct associate professor in NC State’s Department of Chemical and Biomolecular Engineering.


Note to Editors: The study abstract follows.

“Microfluidic Synthesis of Elastomeric Microparticles: A Case Study in Catalysis of Palladium-Mediated Cross-Coupling”

Authors: Jeffrey Bennett, Andrew Kristof, Vishal Vasudevan, Jan Genzer, Jiri Srogl and Milad Abolhasani, North Carolina State University

Published: Feb. 7, AIChE Journal

DOI: 10.1002/aic.16119

Abstract: Palladium (Pd)-loaded poly-hydromethylsiloxane (PHMS) microparticles of tunable size and elasticity are prepared in a capillary-based coaxial flow-focusing microfluidic device constructed using off-the-shelf components. Simultaneous droplet formation and chemical crosslinking processes are performed by tuning the dilution of the cross-linking catalyst in the annular flow of the microreactor, resulting in PHMS microparticles synthesized in a single step. The size of the elastomeric microparticles can be tuned by adjusting the flow rate ratio of the polymer and cross-linker mixture to water, while the elasticity can be tuned by the polymer to cross-linker ratio as well as the flow rate ratio of the polymer mixture to cross-linking catalyst mixture. Microparticle elasticity is characterized by the degree of solvent uptake. Application of the synthesized PHMS microparticles in organic synthesis is demonstrated by producing monodispersed Pd-loaded microparticles and utilizing them as microreaction vessels for continuous Suzuki-Miyaura crosscoupling in a Pd-loaded microparticle-packed bed reactor (µ-PBR).

2 responses on “‘Green’ Catalysis Technique Aims to Boost Pharmaceutical Manufacturing Efficiency

  1. Dr. Cindy Bauman says:

    These are truly brilliant young people to have developed this unique technique.

    Let’s hope that thanks to them many more innovative drugs can be manufactured to help mankind in its fight against disease.


Leave a Reply to Dr. Cindy Bauman Cancel reply

Your email address will not be published. All fields are required.